AstraZeneca
AZN
#49
Rank
โ‚น26.236 T
Marketcap
โ‚น16,923
Share price
-0.15%
Change (1 day)
47.04%
Change (1 year)

Market capitalization of AstraZeneca (AZN)

Market cap: โ‚น26.236 Trillion

As of February 2026 AstraZeneca has a market cap of โ‚น26.236 Trillion. This makes AstraZeneca the world's 49th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AstraZeneca from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น26.236 T1.52%
2025โ‚น25.842 T47.95%
2024โ‚น17.466 T0.31%
2023โ‚น17.413 T0.02%
2022โ‚น17.409 T28.89%
2021โ‚น13.506 T41%
2020โ‚น9.579 T2.65%
2019โ‚น9.332 T41.36%
2018โ‚น6.602 T18.68%
2017โ‚น5.563 T18.71%
2016โ‚น4.686 T-18.43%
2015โ‚น5.745 T1.22%
2014โ‚น5.676 T23.99%
2013โ‚น4.578 T42.63%
2012โ‚น3.209 T0.24%
2011โ‚น3.202 T9.8%
2010โ‚น2.916 T-7.72%
2009โ‚น3.160 T10.71%
2008โ‚น2.854 T16.59%
2007โ‚น2.448 T-32.61%
2006โ‚น3.633 T3.44%
2005โ‚น3.512 T35.57%
2004โ‚น2.590 T-30.52%
2003โ‚น3.729 T28.95%
2002โ‚น2.892 T-26.31%
2001โ‚น3.924 T-7.55%
2000โ‚น4.244 T31.68%
1999โ‚น3.223 T77.85%
1998โ‚น1.812 T34.98%
1997โ‚น1.342 T40.83%
1996โ‚น953.49 B

End of Day market cap according to different sources

On Feb 5th, 2026 the market cap of AstraZeneca was reported to be:

โ‚น52.495 Trillion
by Nasdaq info icon info icon
โ‚น26.236 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น51.803 T 97.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น26.909 T 2.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น13.618 T-48.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น17.166 T-34.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น82.749 T 215.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น10.430 T-60.25%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น2.458 T-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น27.046 T 3.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น10.956 T-58.24%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น10.736 T-59.08%๐Ÿ‡ฌ๐Ÿ‡ง UK